IP Verse

Pfizer Inc. v. uniQure Biopharma B.V. et al. - IPR2021-00925

Explore the PTAB proceeding IPR2021-00925 filed by Pfizer Inc. against uniQure Biopharma B.V. et al. on May 11, 2021. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2021-00925
Filing Date
May 11, 2021
Petitioner
Pfizer Inc.
Respondent
uniQure Biopharma B.V. et al.
Status
Final Written Decision
Respondent Application Number
15650070
Respondent Tech Center
1600
Respondent Patent Number
9982248
Institution Decision Date
Nov 17, 2021
Termination Date
Nov 15, 2022

Decision Documents New

Decision pending - set alert to receive updates

Counsels Involved New

Details of counsels involved in proceeding number IPR2021-00925.

TypeName
Petitioner CounselDov Grossman
Respondent CounselEmily Whelan

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.